Semaglutide 0.25 mg: The Starter Dose (Weeks 1-4 Guide)
0.25 mg is where every Wegovy and compounded semaglutide regimen begins. It's not the therapeutic dose — it's the gut-tolerance dose that makes the therapeutic dose possible.
Semaglutide 0.25 mg is the FDA-required starter dose for Wegovy chronic weight management and the standard starting point for compounded semaglutide. It's intentionally sub-therapeutic — at 0.25 mg, semaglutide doesn't deliver the full 15-17% body-weight reduction Wegovy showed in the STEP 1 NEJM 2021 trial. What it does is prime your GLP-1 receptors and let your gut adapt to delayed gastric emptying without the severe nausea that would happen if you started at a therapeutic dose.
What 0.25 mg does (and doesn't)
At 0.25 mg weekly, semaglutide partially activates GLP-1 receptors throughout the gut, pancreas, and central nervous system. Appetite is mildly suppressed. Gastric emptying slows by 20-40%. Some patients lose 1-3 lbs in the first 4 weeks; others lose none. This is normal and expected — the goal of weeks 1-4 isn't weight loss, it's tolerance building.
The standard Wegovy escalation: 0.25 mg (weeks 1-4) → 0.5 mg (weeks 5-8) → 1.0 mg (weeks 9-12) → 1.7 mg (weeks 13-16) → 2.4 mg (weeks 17+ maintenance). Each step approximately doubles the GLP-1 receptor activation and the appetite-suppression effect. Therapeutic weight loss starts at 0.5-1.0 mg and peaks at 2.4 mg.
Side effects at 0.25 mg
Most patients experience some mild nausea, fatigue, decreased appetite, or constipation in weeks 1-2 as the gut adapts. By week 3-4, these typically fade. Severe side effects (vomiting requiring fluids, persistent diarrhea) are uncommon at 0.25 mg — if they happen, hold at this dose longer before escalating, or contact your clinician.
Trimi 0.25 mg starter protocol
- • Inject once weekly on the same day each week (subcutaneous: abdomen, thigh, or upper arm)
- • Rotate injection sites week-to-week to reduce local skin reactions
- • Stay hydrated (target 80+ oz water/day) — helps with nausea and constipation
- • High-protein meals (~30g per meal) reduce nausea triggers
- • Plan 4 weeks at 0.25 mg before considering escalation to 0.5 mg
Start semaglutide 0.25 mg with Trimi
$99/month annual plan, flat across all titration doses. US-licensed clinicians, free expedited shipping, 503A pharmacy.
Start your visitFAQs
Will I lose weight on semaglutide 0.25 mg?
Modestly. 0.25 mg is the starter dose — it primes your GLP-1 receptors but doesn't deliver the full appetite-suppression effect. Most patients on 0.25 mg for the first 4 weeks see 1-3 lbs of weight loss; the bigger drop comes after escalating to 0.5 mg, 1.0 mg, and beyond. Per the STEP 1 trial protocol (NEJM 2021), 0.25 mg is a tolerance-building dose, not a therapeutic-effect dose.
Why start at 0.25 mg instead of going straight to 2.4 mg?
GI tolerance. Going straight to a therapeutic semaglutide dose causes severe nausea, vomiting, and diarrhea in most patients. The 4-week 0.25 mg starter period lets your gut adapt to delayed gastric emptying and central GLP-1 effects gradually. Per the FDA-approved Wegovy prescribing information, the dose-escalation schedule is mandatory for tolerability.
How long do I stay on 0.25 mg?
4 weeks (weeks 1-4) per the standard Wegovy/Ozempic titration protocol. After 4 weeks at 0.25 mg, clinicians typically escalate to 0.5 mg. If you experience severe GI side effects, you can hold at 0.25 mg for an additional 2-4 weeks before escalating — Trimi clinicians adjust based on individual tolerance.
Will I have side effects at 0.25 mg?
Some patients experience mild nausea, decreased appetite, fatigue, or constipation in weeks 1-2 as the gut adapts. Most side effects fade by week 3-4. The starter dose is specifically designed to be the most tolerable dose of the titration — if you can't tolerate 0.25 mg, escalating to 0.5+ mg will be worse.
Can I stay on 0.25 mg long-term?
Not typically. 0.25 mg is sub-therapeutic for sustained weight management. Patients who plateau quickly and want to maintain at a low dose usually settle at 1.0 mg, not 0.25 mg. If you need a slower titration for tolerability reasons, hold at each step longer rather than staying indefinitely at 0.25 mg.
Is 0.25 mg the same in Wegovy, Ozempic, and compounded semaglutide?
Yes — 0.25 mg is the same active ingredient and dose across all three. The semaglutide molecule is identical. Wegovy and Ozempic are pre-filled pen autoinjectors with 0.25 mg dose-set; compounded semaglutide (via Trimi and similar) is drawn into a syringe from a vial — the patient draws 0.25 mg from the vial concentration. Clinician walks you through the math during onboarding.
How much does semaglutide 0.25 mg cost?
Wegovy 0.25 mg pen list price is approximately $1,349/month — same as any other dose strength because Wegovy is priced per pen, not per mg. Compounded semaglutide via Trimi is $99/month on annual plan, $175/month on month-to-month, flat across all titration doses (0.25 mg through 2.4 mg).
Related reading
Disclaimer: Informational, not medical advice. Compounded semaglutide is prepared per individual prescription by a 503A community sterile compounding pharmacy; not FDA-approved as a finished drug (active ingredient is FDA-approved in Wegovy and Ozempic). Always consult a licensed clinician about dose titration. **The FDA does not review or approve any compounded medications for safety or effectiveness.